Posts in category Healthcare


Canaccord Highlights Upcoming Catalysts For Palatin Technologies, Inc. (PTN) Bulls

John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.

Read more

Valeant Pharmaceuticals Intl Inc (VRX): Analyst Louise Chen Provides Key Takeaways Following a Fireside Chat with CFO

CFO Paul Herendeen sought out to convince investors to put their money into the long game.

Read more

Here’s Why H.C. Wainwright Just Cut the Price Target for Synergy Pharmaceuticals Inc (SGYP) by 50%

Ram Selvaraju slashes his target to $8 on slower Trulance ramp.

Read more

Canaccord Slashes Price Target for Versartis Inc to $9.00 as GHD Drug Flunks Phase 3 Trial

Could Versartis recover after today’s big decline?

Read more

Ask Analysts: Where Versartis Inc (VSAR), Ascendis Pharma A/S (ASND) Stocks Are Heading from Here?

A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.

Read more

Top Analyst Cuts Price Target For Intercept Pharmaceuticals Inc (ICPT) By 50%; Here’s Why

Intercept Sank 40% in September following Dear Doctor and FDA warning letters; Ritu Baral weighs in.

Read more

Alnylam Pharmaceuticals, Inc. (ALNY) Picks Up a Price Target Boost from Cowen Following Stellar Phase III Top-Line Data in FAP

Analyst praises Alnylam’s patisiran as best-in-class, even more confident in its safety and tolerability profile.

Read more

Dynavax Technologies Corporation (DVAX) Gains a Cantor Bull on Back of Compelling HBV Opportunity

Analyst initiates a bullish perspective on Dynavax, ascribing a probability of 95% approval for its lead asset.

Read more

Cantor Asserts That Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Loan Amendments Get Rid of Meaningful Overhang on Stock

Analyst says share weakness does not stem from encouraging news, but points to other underlying concerns.

Read more

Supernus Pharmaceuticals Inc (SUPN) Investors Are Scared Off by Elimination of Low SPN-810 Dose; Cantor Makes a Bullish Case

Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.

Read more